Common variable immunodeficiency. Old questions are getting clearer

Allergologia et Immunopathologia

Volumn 34, Issue 6, 2006, Pages 263-275

  Blanco Quirós, Alfredo ^a,c   Solis Sanchez P ^b   Garrote Adrados, J A ^b   Arranz Sanz, E ^a  

^a Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

^b Hospital Clinico   (Spain)

^c UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Antibody class switch; Autoimmunity; B cells; CD19; Common variable immunodeficiency; ICOS; TACI

Indexed keywords

ANTIBODY; APRIL PROTEIN; CIMETIDINE; ETANERCEPT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLIXIMAB; PROTEIN BAFF; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CELL MATURATION; CELL SURVIVAL; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; MEMORY CELL; NONHUMAN; PATHOGENESIS; PNEUMONIA; RECURRENT DISEASE; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 33846359604     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095875     Document Type: Article

References (103)

1. Notarangelo L, Casanova J-L, Conley ME, Chapel H, Fischer A, Puck J, et al. for the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committees. J Allergy Clin Immunol. 2006;117:883-96.
2. a ed. Madrid: Ergón, (in press).
3. Vorechovsky I, Zetterquit H, Paganelli R, Koskinen S, Webster ADB, Bjorkander J, et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunopathol. 1995;77:185-92.
4. Sneller MC. Common variable immunodeficiency. Am J Med Sci. 2001;321:42-8.
5. Ochs HD, Stiehm ER, Winkelstein JA. Antibody deficiencies. In: Stiehm ER, Ochs HD, Winkelstein JA, editors. Immunologic disorders in infants and children. 5th ed. Filadelfia: Elsevier; 2004. p. 356-426.
6. Cunningham-Rundles C. Selective IgA deficiency. In: Stiehm ER, Ochs HD, Winkelstein JA, editors. Immunologic disorders in infants and children. 5th ed. Filadelfia: Elsevier; 2004. p. 427-46.
7. Sorensen RU, Moore C. Antibody deficiency syndromes. Pediatr Cl N Amer. 2000;47:1225-52.
8. Fieschi C, Malphettes M, Galicier L, Oksenhendler E. Adult-onset primary hypogammaglobulinemia. Presse Med 2006;35:887-894.
9. Bonilla FA, Geha RS. 2. Update on primary immunodeficiency diseases. J Allergy Clin Immunol. 2006;117 Suppl 2:5435-41.
10. Bayry J, Hermine O, Webster DA, Levy Y, Kaveri SV. Common variable immunodeficiency: the immune system in chaos Trends Mol Med. 2005;11:370-6.
11. Cuss AK, Avery DT, Cannons JL, Yu LJ, Nichols KE, Shaw PJ, Tangye SG. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol. 2006; 176:1506-16.
12. Vlkova M, Thon V, Sarfyova M, Blaha L, Svobodnik A, Lokaj J, Litzman J. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients. Clin Exp Immunol. 2006;143:373-9.
13. Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23:385-400.
14. Dektova D, de Gracia J, Hernández M. Caracterización clínico-epidemiológica de los pacientes con inmunodeficiencia variable común clasificados según fenotipo de los linfocitos. Inmunología. 2005;24:45-7.
15. Ko J, Radigan L, Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol. 2005;118:37-41.
16. Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol. 2005;115:412-7.
17. Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G R et al. Severe deficiency of switched memory B cells (CD27 + IgM-IgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify heterogeneous disease. Blood. 2002;99:1544-51.
18. Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol. 2006;120:310-318.
19. Viallard JF, Blanco P, Andre M, Etienne G, Liferman F, Neau D, et al. CD8 + HLA-DR + T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin Immunol. 2006;119:51-58.
20. Holm AM, Tjonnfjord G, Yndestad A, Beiske K, Muller F, Aukrust P, Froland SS. Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency-association with neutropenia. Clin Exp Immunol. 2006;144:418-24.
21. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Galicier L, Lepelletier Y, Webster D, et al. Common variable immunodeficiency is associated with defective function of dendritic cells. Blood. 2004;104:2441-2443.
22. Scott-Taylor TH, Green MR, Eren E, Webster AD. Monocyte derived dendritic cell responses in common variable immunodeficiency. Clin Exp Immunol. 2004;138:484-90.
23. Martinez-Pomar N, Raga S, Ferrer J, Pons J, Munoz-Saa I, Julia MR, et al. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol. 2006;144:233-8.
24. Cunningham-Rundles C, Raigan L. Deficient IL-12 and dendritic cell function in common variable immunodeficiency. Clin Immunol. 2005;115:147-53.
25. Goldacker S, Warnatz K. Tacling the heterogeneity of CVID. Current Opin Allergy Clin Immunol. 2005;5:504-9.
26. Holm AM, Aukrust P, Damas JK, Muller F, Halvorsen B, Froland SS. Abnormal interleukin-7 function in common variable immunodeficiency. Blood. 2005;105:2887-90.
27. Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol. 2006;176:1978-87.
28. Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25:57-62.
29. Martínez García MA, de Rojas MD, Nauffal Manzur MD, Muñoz Pamplona MP, Compte Torrero L, Perpiña Tordera M. Respiratory disorders in common variable immunodeficiency. Resp Med. 2001;95:191-5.
30. Vendrell M, de Gracia J, Rodrigo MJ, Cruz MJ, Alvarez A, Garcia M, Miravitlles M. Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology. Chest. 2005;127:197-204.
31. Bates CA, Ellison MC, Lynch DA. Granulomatosis-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004;114:415-21.
32. Wheat WH, Cool CD, Morimoto Y, Rai PR, Kirkpatrick CH, Lindenbaum BA, et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med. 2005;202:479-84.
33. Morimoto Y, Routes JM. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep. 2005;5: 370-5.
34. Abdel-Naser MB, Wollina U, El Hefnawi MA, Habib MA, El Okby M. Non-sarcoidal, non-tuberculoid granuloma in common variable immunodeficiency. J Drugs Dermatol. 2006;5: 370-2.
35. Fassano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ, et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine. 1996;75:251-61.
36. Mudter J, Wirtz S, Weigmann B, Tiede I, Tubbe I, Kiesslich R, et al. Crohn's-like colitis in a patient with immunodeficiency associated with a defect in expression of inducible costimulator. Dig Dis Sci. 2006;51:711-717.
37. Bosworth BP, Sanders A, Maltz C. Common variable immunodeficiency masquerading as Crohn's ileocolitis. Inflamm Bowel Dis. 2006;12:151-2.
38. Dray X, Treton X, Mazeron MC, Lavergne-Slove A, Joly F, Mimram D, et al. Herpes simplex virus type 1 colitis in a patient with common variable immunodeficiency syndrome. Eur J Gastroenterol Hepatol. 2006;18:541-4.
39. Zullo A, Romiti A, Rinaldi V, Vechioni A, Tomeo S, Aiuti F et al. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45:77-81.
40. Perez-Castellano MT, Sanz E, Vega F, Matamores N. Helicobacter pylori infection in common variable immunodeficiency Med Clin (Barc). 2006;126:599.
41. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34-48.
42. Lin LH, Tsai CN, Liu MF, Wang CR. Common variable immunodeficiency mimicking rheumatoid arthritis with Sjogren's syndrome. J Microbiol Immunol Infect. 2005;38:358-60.
43. Sarmiento E, Mora R, Rodriguez-Mahou M, Rodriguez Molina J, Fernández Cruz E, Carbone J. Enfermedad autoinmune en inmunodeficiencias primarias de anticuerpos. Allergol et Immunopathol. 2005;33:69-73.
44. Heeney MM, Zimmerman SA, Ware RE. Childhood autoimmune cytopenia secondary to unsuspect common variable immunodeficiency. J Pediatr. 2003;143:662-5.
45. Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O. et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: Analysis of 21 cases and review of the literature. Medicine. 2004;83:254-63.
46. Iglesias P, Ferreira A, Diez JJ. Common variable immunodeficiency in adult woman with IDDM. Diabetes Care. 1998;21: 1029.
47. Metin A, Tez Can I, Ozyurek H. IDDM in adolescent patient with common variable immunodeficiency. Dabetes Care. 1997;20:677-8.
48. López Cruz MC, Martin Mateos MA, Giner Muñoz MT, Plaza Martin AM, Sierra Martínez JI. Common variable immunodeficiency, insulin-dependent diabetes mellitus and celiac disease. Allergol et Immunopathol. 2000;28:323-7.
49. Cunningham-Rundles S, Cooper DL, Duffy TP, Strauchen J. Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol. 2002;69: 171-8.
50. Desar IM, Keuter M, Raemaekers JM, Jansen JB, van Krieken JH, van der Meer JW. Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency. Neth J Med. 2006;64:136-40.
51. Berglund LJ, Jones GJ, Murali R, Fulcher DA. TACI mutation with invasive polyclonal CD8 + T-cell lymphoproliferation in a patient with common variable immunodeficiency. J Allergy Clin Immunol. 2006;117:870-7.
52. Spickett GP, Farrant J, North ME, Zhang J, Morgan L, Webster DB. Common variable immunodeficiency: how many diseases? Immunol Today. 1997;18:325-8.
53. Español T, Catala M, Hernández M, Caragol I, Bertrán JM. Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol. 1996;80:333-5.
54. White WB, Ballow M. Modulation of supressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia. N Engl J Med. 1985;312:198-202.
55. Cunningham-Rudles C, Kazbay K, Hassett J, Zhou Z, Mayer L. Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethilene glycol conjugated interleukin-2. N Engl J Med. 1994;331: 918-21.
56. Blanco Quiros A. Inmunodeficiencia variable común. In: Blanco Quirós, Muñoz López, Martin Materos, editores. Tratamiento de las enfermedades inmunitarias, alérgicas y reumáticas en ninõs y adolescentes. Barcelona: Espaxs; 1999. p. 68-9.
57. Gracia J de, Vendrell M, Guarner L, Vidal R, Miravitlles M, Mayordomo C, Morell F. Utilización de gammaglobuline humana en el tratamiento de la inmunodeficiencia variable común. Med Clin (Barcelona) 1995;104:201-6.
58. Gracia J de, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la Rosa D, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Pharmacol. 2004;4:745-53.
59. Gardulf A, Hansen S, Johansson K, Linden M. Rapid subcutaneous IgG replacement therapy in children and adults - 20 years of clinical experience. Immunología. 2005;24:50-3.
60. Gardulf A, Asensio O, Bernatowska E, Bock A, Costa-Carvalho BT, Granert C et al. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol. 2004;114:936-41.
61. Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. Clin Immunol. 2000;20:94-100.
62. Swierkot J, Lewandowicz-Uszynska A, Chlebicki A, Szmyrka-Kaczmarek M, Polanska B, Jankowski A, Szechinski J. Rheumatoid arthritis in a patient with common variable immunodeficiency: difficulty in diagnosis and therapy. Clin Rheumatol. 2006;25:92-4.
63. Lin JH, Liebhaber M, Roberts RL, Dyer Z, Stiehm ER. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol. 2006;117:878-82.
64. Thatayatikom A, Thatayatikom S, White AJ. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature Ann Allergy Asthma Immunol. 2005;95:293-300.
65. Amsden GW. Anti-inflammatory effects of macrolides. An underappreciated benefit in the treatment of community acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother. 2005;55: 10-21.
66. Spickett GP. Current perspectives on common variable immunodeficiency (CVID). Clin Exp Allergy. 2001;31:536-42.
67. Wright JJ, Birx DL, Wagner DK, Waldmann TA, Blaese RM, Fleisher TA. Normalization of antibody responsiveness in a patient with common variable hypogammaglobulinemia and HIV infection. N Engl J Med. 1987;317:1516-20.
68. Blom B, Spits H. Development of human lymphoid cells. Annu Rev Immunol. 2006;24:287-320.
69. Seising E. Ig class switching: targeting the recombinational mechanism. Cur Opin Immunol. 2006;18:249-54.
70. He B, Quiao X, Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol. 2004;173:4479-91.
71. Litinsky MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, et al. CDs induce CD40-independent immunoglobulin class switching through Bias and APRIL. Nat Immunol. 2002;3: 822-9.
72. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005;37:829-34.
73. Grimbacher B, Salzer U, Franco L, Warnatz K. The genetics of hypogammaglobulinemia. Inmunologia. 2005;24:42-4 (Generalidades de todas las moléculas. Taci 27/300 IDVC).
74. Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37:820-8.
75. Scapini P, Carletto A, Nardelli B, Calzetti F, Roschke V, Merigo F, et al. Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils implications for inflammatory disease. Blood. 2005;105:830-7.
76. MacKay F, Schnaeider P, Rennert P, Browing J. BAFF and APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2003; 21:231-64.
77. MacKay F, Kalled SL. TNF ligands and receptors in autoimmunity: an update. Curr Opin Immunol. 2002;14:783-90.
78. Cheema GS, Roschke V, Hubert DM, Stohl W. Elevated serum B-lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001;44: 1313-9.
79. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. Association of BAFF/BLyS overexpression and altered B-cell differentiation with Sjogren sindrome. J Clin Invest. 2002;109:59-68.
80. Castigli E, Scout S, Dedeglu F, Bryce P, Jabara H, Bhan AK et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA. 2004;101:3903-8.
81. Deshayes F, Lapree G, Portier A, Richard Y, Pencalet P, Mahieu-Caputo D, et al. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene. 2004;23:3005-12.
82. MacKay F, MacKay Ch. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 2002;23: 113-5.
83. Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Cur Opin Allergy Clin Immunol. 2005;5:496-503.
84. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, et al. An essential role of BAFF in the normal development of B cells through a BCMA independent pathway. Science. 2001;293;2111-4.
85. Van M, Wang H, Chan B, Roose-Girma M, Erickson S, Baker T, et al. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol. 2001;2:638-43.
86. Martin F, Dixit VM. Unraveling TACIt functions. Nat Genet. 2005;37:793-4.
87. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M et al. Germline mutations in the extracellular domains of the 55Kda TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory sindromes. Cell. 1999;97:133-44.
88. Thomas KT, Feder HM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999;135:15-21.
89. Weyhreter H, Schwarte M, Kristensen TD, Valerius NH, Paeregaard A. A new mutation causing autosomal dominant periodic fever syndrome in a Danish family. J Pediatr. 2003;142:191-3.
90. Levy J, Español T, Thomas C, Fisher A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM sindrome. J Pediatr. 1997;131:47-54.
91. Kutukculer N, Moratto D, Aydinok Y, Lougaris V, Aksoylar S, Plebani A, et al. Disseminated Cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Pediatr. 2003;142:194-6.
92. Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, et al. Mutations of CD40 gene cause an autosomal recesive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA. 2001;98:12614-9.
93. Infante AJ, Britton HA, DeNapoli T, Middelton LA, Lenardo MJ, Jackson CE et al. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome and autoimmunity. J Pediatr. 1998;133:629-33.
94. Morra M, Silander O, Calpe S, Choi M, Oetgen H, Myers L, et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency sindrome. Blood. 2001;98:1321-5.
95. Castigli E, Wilson SA, Scout S, Dedeglu F, Xu S, Lamp KP et al. TACI and Baff-R mediate isotype switching in B cells. J Exp Med. 2005;201:35-9.
96. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, et al. Homocygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4:261-8.
97. Salzer U, Maul-Pavicic A, Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol. 2004;113:234-40.
98. Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol. 2006;117:740-6.
99. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF. Anormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 1995;3:39-50.
100. Rudd CE. Disabled receptor signaling and new primary immunodeficiency disorders. N Engl J Med. 2006;354:1874-77.
101. van Zelm M, Reisli I, van der Burg M, Castano D, Van Noesel CJM, van Tol MJD, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006;354: 1901-12.
102. Losi CG, Salzer U, Gatta R, Lougaris V, Cattaneo G, Meini A, et al. Mutational Analysis of Human BLyS in Patients with Common Variable Immunodeficiency. J Clin Immunol. 2006;26:396-9.
103. Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto T, Tokunaga K. Analysis of the association of human BLyS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun. 2002;3:424-9.